Studies addressing the relationship between peripheral blood CD4 + T cells, CD8 + T cells, Treg cells, and B cells and the effectiveness and progression-free survival of immunotherapy for advanced gastric cancer are lacking. The gene discussed is CD4; the disease is gastric cancer.